Summary
Pretreatment with taglutimide significantly decreased the plasma dicoumarol level and shortened the duration of hexobarbital-induced narcosis in rats. Furthermore, taglutimide pretreatment accelerated thein vitro metabolism of dicoumarol, hexobarbital, o-nitrophenyl acetate and procaine, but not of 3,4-benzpyrene, as assayed in the 10,000xg supernatant fraction of rat liver homogenate. No definite increase was observed in liver wet weight, nor in the amount of microsomal and total liver protein in comparison with the control values. No marked differences were found between the effects of short-(4-day) and long-term (17-day) pretreatment on any of the studied parameters. The changes in drug metabolism and liver protein observed after taglutimide pretreatment differed from those observed after pretreatment with either phenobarbital or 3,4-benzpyrene. Taglutimide, like other inducing agents, is lipophilic, but differs from them in not being a substrate of monooxygenases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Koehler F. and Koch H. (1974): Teratologische Untersuchungen der Thalidomid-aehnlichen Verbindungen K-2004 und K-2604 an Maus und Ratte. Arzneim.-Forsch.,24, 1616–1619.
Argyropoulos G., Lanner G. and Pasquali E. (1976): Klinische und elektroenzephalographische Studien mit einem neuen Hypnosedativum K-2004. Wien. Med. Wschr.,126, 75–77.
Schuetzenberger W.G., Kolassa N., Wiener H., Kraupp O., and Tuisl E. (1979): Pharmacological properties of biglumide, a new sedative hypnotic drug. Arzneim.-Forsch.,29, 1146–1150.
Remmer H. (1962): in “Symp. Redoxfunktionen Cytoplasmatischer Strukturen”, Gemeinsame Tagung Dtsch. Ges. Physiol. Chem. und Oesterr. Biochem. Ges. in Wien, p. 75.
Kato R., Chiesara E. and Vassanelli P. (1964): Further studies on the inhibition and stimulation of microsomal drug-metabolizing enzymes of rat liver by various compounds. Biochem. Pharmac.,13, 69–83.
Conney A.H. (1967): Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev.19, 317–366.
Hunter J. and Chasseaud L.F. (1976): Clinical aspects of microsomal enzyme induction. In “Progress in Drug Metabolism” (J.W. Bridges and L.F. Chasseaud, eds.), Vol. 1, p. 129–191. John Wiley & Sons, London.
Zaroslinski J., Browne R. and Possley L. (1972): Effect of subacute administration of methaqualone, phenobarbital and glutethimide on plasma levels of bishydroxycoumarin. Arch. int. Pharmacodyn.,195, 185–191.
Axelrod J., Cooper J.R. and Brodie B.B. (1949): Estimation of dicumarol, 3,3-methylenebis(4-hydroxycoumarin) in biological fluids. Proc. Soc. Exp. Biol. Med.,70, 693–695.
Conney A.H., Davison C., Gastel R. and Burns J.J. (1960): Adaptive increases in drug-metabolizing enzymes induced by phenobarbital and other drugs. J. Pharmacol. Exp. Ther.,130, 1–8.
Mazel P. (1971): Experiments illustrating drug metabolism in vitro. In “Fundamentals of Drug Metabolism and Drug Disposition” (B.N. La Du, H.G. Mandel and E.L. Way, eds.), p. 546–582, Williams & Wilkins Co., Baltimore.
Layne E. (1957). Spectrophotometric and turbidimetric methods for measuring proteins. In “Methods in Enzymology” (S.P. Colowick and N.O. Kaplan, eds.), Vol. 3, p. 447–454, Academic Press, New York.
Cooper J.R. and Brodie B.B. (1955): The enzymatic metabolism of hexobarbital (evipal). J. Pharmacol. Exp. Ther.,114, 409–417.
Remmer H. and Merker H.J. (1963): Drug-induced changes in the liver endoplasmic reticulum: Association with drug-metabolizing enzymes. Science,142, 1657–1658.
Conney A.H., Miller E.C. and Miller J.A. (1957): Substrate-induced synthesis and other properties of benzpyrene hydroxylase in rat liver. J. Biol. Chem.,228, 753–766.
Krisch K. (1966): Reaction of a microsomal esterase from hog-liver with diethyl p-nitrophenyl phosphate. Biochim. Biophys. Acta.,122, 265–280.
Koch-Weser J. and Sellers E.M. (1971): Drug interactions with coumarin anticoagulants. I. New. Engl. J. Med.,285, 487–498.
Barker W.M., Hermodson M.A. and Link K.P. (1970): The metabolism of 4-C14-warfarin sodium by the rat. J. Pharmacol. Exp. Ther.,171, 307–313.
Kaighen M. and Williams R.T. (1961): Metabolism of coumarin-3-C14. J. med. pharm. Chem.,3, 25–43.
Pischek G., Kaiser E. and Koch H. (1974): Thalidomid-Analoga, 5. Mitt.: Untersuchungen zum Metabolismus der Thalidomid-aehnlichen Verbindung K-2004. Monatsh. Chem.,105, 74–79.
Pischek G. and Koch H. (1976): Thalidomid-Analoga, 7. Mitt.: Metabolisierung und Elimination der Thalidomidaehnlichen Verbindungen K-2004 bei der Ratte. Arch. Pharm.,309, 62–69.
Aggeler P.M. and O’Reilly R.A. (1969): Effect of heptabarbital on the response to bishydroxycoumarin in man. J. Lab. Clin. Med.,74, 229–238.
Conney A.H. (1971): Environmental factors influencing drug metabolism. In “Fundamentals of Drug Metabolism and Drug Disposition” (B.N. La Du, H.G. Mandel and E.L. Way, eds.), p. 253–278, Williams & Wilkins Co., Baltimore.
Breckenridge A., Orme M.L’E., Davies L., Thorgeirsson S.S. and Davies D.S. (1973): Dose-dependent enzyme induction. Clin. Pharmacol. Ther.,14, 514–520.
Moroi K. and Satoh T. (1975): Modification of procaine metabolism in rat liver after administration of phenobarbital or ethyl p-nitrophenyl phenylphosphonothioate. Biochem. Pharmac.,24, 1436–1438.
Gram T.E. and Gillette J.R. (1971): Biotransformation of drugs. In “Fundamentals of Biochemical Pharmacology” (Z.M. Bacq, ed.), p. 571–609, Pergamon Press, Oxford.
Goldschmidt S. and Wehr R. (1957): Ueber Barbiturate, III. Mitteilung. Der Metabolismus von Veronal. Hoppe-Seyler’s Z. Physiol. Chem.,308, 9–19.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wiener, H., Krivanek, P., Tuisl, E. et al. Induction of drug metabolism in the rat by taglutimide, a sedative-hypnotic glutarimide derivative. European Journal of Drug Metabolism and Pharmacokinetics 5, 93–97 (1980). https://doi.org/10.1007/BF03189451
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189451